OR WAIT null SECS
February 02, 2014
FDA urges manufacturers to examine how shape, size, and color may affect patient safety and enhance treatment adherence.
January 02, 2014
Regulators work with manufacturers to improve systems for measuring product performance and manufacturing reliability.
December 02, 2013
New policies and products seek to maintain access to pain medicines while curbing rampant abuse.
November 02, 2013
Legislators agree on a limited bill affirming FDA authority over compounders while setting up a process for national drug tracking.
Regulators hope new standards will stop illegal drug imports, but manufacturers fear they may stifle innovation.
October 02, 2013
Manufacturing standards are considered key to preventing drug recalls and shortages.
August 02, 2013
Nanomedicines have been authorized by European licensing agencies for more than 30 years but are still posing regulatory difficulties.
Appropriate use of medications promises to improve patient care and curb spending, prompting pharmacists, public health authorities, and manufacturers to promote multiple adherence strategies.
FDA funds research to further development of innovative generics, while working to address review and approval issues.
July 02, 2013
Compounding, tracking legislation moves forward